GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » Net Margin %

Merus Labs International (Merus Labs International) Net Margin % : -5.18% (As of Mar. 2017)


View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Merus Labs International's Net Income for the three months ended in Mar. 2017 was $-0.88 Mil. Merus Labs International's Revenue for the three months ended in Mar. 2017 was $16.92 Mil. Therefore, Merus Labs International's net margin for the quarter that ended in Mar. 2017 was -5.18%.

The historical rank and industry rank for Merus Labs International's Net Margin % or its related term are showing as below:


MSLI's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.765
* Ranked among companies with meaningful Net Margin % only.

Merus Labs International Net Margin % Historical Data

The historical data trend for Merus Labs International's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus Labs International Net Margin % Chart

Merus Labs International Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -223.83 -10.93 -30.83 -0.49 -10.39

Merus Labs International Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.38 -19.70 -0.22 -24.23 -5.18

Competitive Comparison of Merus Labs International's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Merus Labs International's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merus Labs International's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merus Labs International's Net Margin % distribution charts can be found below:

* The bar in red indicates where Merus Labs International's Net Margin % falls into.



Merus Labs International Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Merus Labs International's Net Margin for the fiscal year that ended in Sep. 2016 is calculated as

Net Margin=Net Income (A: Sep. 2016 )/Revenue (A: Sep. 2016 )
=-7.216/69.481
=-10.39 %

Merus Labs International's Net Margin for the quarter that ended in Mar. 2017 is calculated as

Net Margin=Net Income (Q: Mar. 2017 )/Revenue (Q: Mar. 2017 )
=-0.876/16.918
=-5.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merus Labs International  (NAS:MSLI) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Merus Labs International Net Margin % Related Terms

Thank you for viewing the detailed overview of Merus Labs International's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Merus Labs International (Merus Labs International) Business Description

Traded in Other Exchanges
N/A
Address
Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines